NCT05821595View on ClinicalTrials.gov

JYB1907 in Subjects With Advanced Solid Tumors

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

September 15, 2024

Study Completion Date

October 31, 2024

Conditions
Solid Tumor
Interventions
DRUG

JYB1907

for injection

Sponsors

Lead Sponsor

Jemincare
All Listed Sponsors
lead

Jemincare

INDUSTRY

NCT05821595 - JYB1907 in Subjects With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter